{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:58:49Z","timestamp":1790834329005,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10096-023-04669-8","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T01:02:06Z","timestamp":1695690126000},"page":"1327-1335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Performances of ICT Toxoplasma IgG-IgM test in comparison with Vidas\u00ae toxo competition to determine the immune status against Toxoplasma gondii"],"prefix":"10.1007","volume":"42","author":[{"given":"Sylvie","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Piarroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Tesic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Abeleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadhira","family":"Houhou-Fidouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Nicaise-Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luce","family":"Landraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-3847","authenticated-orcid":false,"given":"Sandrine","family":"Houz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"issue":"9425","key":"4669_CR1","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O (2004) Toxoplasmosis. The Lancet 363(9425):1965\u20131976. https:\/\/doi.org\/10.1016\/S0140-6736(04)16412-X","journal-title":"The Lancet"},{"key":"4669_CR2","doi-asserted-by":"publisher","unstructured":"Wallon M, Peyron F (2018) Congenital toxoplasmosis: a plea for a neglected disease. Pathogens 7(1):25. https:\/\/doi.org\/10.3390\/pathogens7010025","DOI":"10.3390\/pathogens7010025"},{"issue":"3","key":"4669_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/JCM.42.3.941-945.2004","volume":"42","author":"JS Remington","year":"2004","unstructured":"Remington JS, Thulliez P, Montoya JG (2004) Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 42(3):941\u2013945. https:\/\/doi.org\/10.1128\/JCM.42.3.941-945.2004","journal-title":"J Clin Microbiol"},{"key":"4669_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2015.09.009","author":"O Villard","year":"2016","unstructured":"Villard O, Cimon B, L\u2019Ollivier C et al (2016) Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis. Elsevier Enhanc Read. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.09.009","journal-title":"Elsevier Enhanc Read"},{"key":"4669_CR5","unstructured":"Toxoplasma ICT IgG-IgM - instruction for use - LDBio - February 2019. https:\/\/ldbiodiagnostics.com\/wp-content\/uploads\/simple-file-list\/NOTICES\/2_RAPID-TESTS\/FRANCAIS\/TOXOPLASMA-ICT-IgG-IgM-vs12-fr-en.pdf. Accessed 23 Sept 2023"},{"key":"4669_CR6","unstructured":"Valtaud E, Lacroix C, Rodier MH et al (1991) Critical study of ELISA technique and high sensitivity direct agglutination test for the screening of antitoxoplasma IgG.  Ann Biol Clin 49(7):397\u2013400"},{"key":"4669_CR7","unstructured":"VIDAS toxo comp\u00e9tition - instruction for use - biom\u00e9rieux - April 2006. http:\/\/www.biologiemarine.com\/___fiches\/APIpdf\/VIDAS%C2%AETOXO%20Comp%C3%A9tition-_06361_-_N_-_30211.pdf. Accessed 7 Aug 2021"},{"key":"4669_CR8","unstructured":"Toxo Ig G - Architect system - Abbot diagnostics - instruction for use - January 2009. https:\/\/www.ilexmedical.com\/files\/PDF\/ToxoIgG_ARC.pdf. Accessed 4 Mar 2021"},{"issue":"12","key":"4669_CR9","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1128\/JCM.01193-16","volume":"54","author":"O Villard","year":"2016","unstructured":"Villard O, Cimon B, L\u2019Ollivier C et al (2016) Help in the choice of automated or semiautomated immunoassays for serological diagnosis of toxoplasmosis: evaluation of nine immunoassays by the French National Reference Center for Toxoplasmosis. J Clin Microbiol 54(12):3034\u20133042. https:\/\/doi.org\/10.1128\/JCM.01193-16","journal-title":"J Clin Microbiol"},{"key":"4669_CR10","doi-asserted-by":"publisher","unstructured":"Fricker-Hidalgo H, Bailly S, Brenier-Pinchart MP et al (2020) How to estimate time of infection with Toxoplasma gondii in pregnant women. Use of specific IgG and IgM kinetics by 7 techniques on 691 sera. Diagn Microbiol Infect Dis 96(4):114987. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.114987","DOI":"10.1016\/j.diagmicrobio.2020.114987"},{"key":"4669_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1051\/parasite\/2021035","volume":"28","author":"F Robert-Gangneux","year":"2021","unstructured":"Robert-Gangneux F, Guegan H (2021) Anti-Toxoplasma IgG assays: what performances for what purpose? Syst Rev Parasite 28:39. https:\/\/doi.org\/10.1051\/parasite\/2021035","journal-title":"Syst Rev Parasite"},{"key":"4669_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cca.2016.10.023","volume":"464","author":"E Chapey","year":"2017","unstructured":"Chapey E, Wallon M, Peyron F (2017) Evaluation of the LDBIO point of care test for the combined detection of toxoplasmic IgG and IgM. Clin Chim Acta 464:200\u2013201. https:\/\/doi.org\/10.1016\/j.cca.2016.10.023","journal-title":"Clin Chim Acta"},{"issue":"12","key":"4669_CR13","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1128\/JCM.01106-17","volume":"55","author":"C Mahinc","year":"2017","unstructured":"Mahinc C, Flori P, Delaunay E et al (2017) Evaluation of a new immunochromatography technology test (LDBio Diagnostics) to detect Toxoplasma IgG and IgM: comparison with the routine architect technique. J Clin Microbiol 55(12):3395\u20133404. https:\/\/doi.org\/10.1128\/JCM.01106-17","journal-title":"J Clin Microbiol"},{"issue":"2","key":"4669_CR14","first-page":"314","volume":"32","author":"Y Sukthana","year":"2001","unstructured":"Sukthana Y, Chintana T, Supatanapong W, Siripan C, Lekkla A, Cheabchalrad R (2001) Predictive value of latex agglutination test in serological screening for Toxoplasma gondii. Southeast Asian J Trop Med Public Health 32(2):314\u2013318","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"6","key":"4669_CR15","doi-asserted-by":"publisher","first-page":"e0005670","DOI":"10.1371\/journal.pntd.0005670","volume":"11","author":"IJ Begeman","year":"2017","unstructured":"Begeman IJ, Lykins J, Zhou Y et al (2017) Point-of-care testing for Toxoplasma gondii IgG\/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. Plos Negl Trop Dis 11(6):e0005670. https:\/\/doi.org\/10.1371\/journal.pntd.0005670","journal-title":"Plos Negl Trop Dis"},{"issue":"5","key":"4669_CR16","doi-asserted-by":"publisher","first-page":"e23749","DOI":"10.1002\/jcla.23749","volume":"35","author":"R Ben-Abdallah","year":"2021","unstructured":"Ben-Abdallah R, Kalboussi Y, Bellali H et al (2021) Contribution of the Toxoplasma ICT IgG IgM\u00ae test in determining the immune status of pregnant women against toxoplasmosis. J Clin Lab Anal 35(5):e23749. https:\/\/doi.org\/10.1002\/jcla.23749","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"4669_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3347\/kjp.2013.51.4.485","volume":"51","author":"I Khammari","year":"2013","unstructured":"Khammari I, Saghrouni F, Yaacoub A et al (2013) IgG Western Blot for confirmatory diagnosis of equivocal cases of toxoplasmosis by EIA-IgG and fluorescent antibody test. Korean J Parasitol 51(4):485\u2013488. https:\/\/doi.org\/10.3347\/kjp.2013.51.4.485","journal-title":"Korean J Parasitol"},{"issue":"7","key":"4669_CR18","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1128\/JCM.00182-08","volume":"46","author":"J Franck","year":"2008","unstructured":"Franck J, Garin YJF, Dumon H (2008) LDBio-toxo II immunoglobulin G western blot confirmatory test for anti-Toxoplasma antibody detection. J Clin Microbiol 46(7):2334\u20132338. https:\/\/doi.org\/10.1128\/JCM.00182-08","journal-title":"J Clin Microbiol"},{"issue":"7","key":"4669_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/pl00011289","volume":"20","author":"A Roberts","year":"2001","unstructured":"Roberts A, Hedman K, Luyasu V et al (2001) Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 20(7):467\u2013474. https:\/\/doi.org\/10.1007\/pl00011289","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4669_CR20","doi-asserted-by":"publisher","unstructured":"Mandelbrot L, Kieffer F, Wallon M et al (2021) Toxoplasmose pendant la grossesse\u202f: proposition actuelle de prise en charge pratique. Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &S\u00e9nologie 49(10):782\u2013791. https:\/\/doi.org\/10.1016\/j.gofs.2021.03.003","DOI":"10.1016\/j.gofs.2021.03.003"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-023-04669-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T12:04:06Z","timestamp":1697717046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-023-04669-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["4669"],"URL":"https:\/\/doi.org\/10.1007\/s10096-023-04669-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"12 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The USA sending was exempted by University of Chicago investigational research board as it was impossible to link samples to patients and residual samples that are otherwise discarded were utilized. For French samples, only the staffs from the hospital had access to the laboratory results. Interpretation was performed anonymously. According to the French law, patients were informed that their samples might be used for research and they retained the right to oppose the use of their anonymized medical data for research purpose. Dedicated ethical approval and individual patient consent were not necessary for this type of research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"In Paris and Lyon, the authors in Paris and Lyon have no relevant financial or non-financial interests to disclose except R Piarroux who was employed by the LDBio Company. In Chicago, at LDBio Diagnostics, Raphael Piarroux PharmD, PhD (RP) was the R&D Director Scientist until January 13, 2023, and during that time these studies were planned and discussed with RMc Leod (RMc). A patent application was submitted by D. Limonne, PharmD with the scientists at the University of Chicago and in Lyon, France in August 2018. This application is pending review in the United States Patent Office in accordance with the US Bayh Dole laws. This is for the development of the whole blood point of care test and the practical clinical utility of the ICT to guide treatment for gestational infection to prevent congenital toxoplasmosis. This is to insure its continued high-quality performance and reproducibility of the results described herein. In this collaborative work, the scientist RP and DL at LDBio provided insights and knowledge from their earlier work in creating the ICT. The scientists at LDBio did not interfere with the obtaining of samples, performing of the tests, the recording and interpretation of the results, nor the reported conclusions of any work at any academic site. All this work was performed independently in the academic centers. There was no payment to those at the University of Chicago.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}